Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Versartis, Inc. | 175,000 | reported | 24 Jan 2022 | tx 11+590,813 |
| Virpax Pharmaceuticals, Inc. | 112,000 | reported | 29 Jan 2024 | tx 3+312,000 |
| ADIAL PHARMACEUTICALS, INC. | 9,000 | reported | 29 May 2025 | tx 2+49,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2025 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 9,000 | 0.00 USD | deriv |
| 16 Nov 2024 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 40,000 | 0.00 USD | deriv |
| 29 Jan 2024 | GRANT_AWARD | Virpax Pharmaceuticals, Inc. | 112,000 | 0.00 USD | deriv |
| 20 Jun 2023 | GRANT_AWARD | Virpax Pharmaceuticals, Inc. | 100,000 | 0.00 USD | deriv |
| 24 Jan 2022 | GRANT_AWARD | Versartis, Inc. | 175,000 | 0.00 USD | deriv |
| 29 Jun 2021 | PURCHASE | Versartis, Inc. | 1,000 | 5.31 USD | |
| 25 Jan 2021 | GRANT_AWARD | Versartis, Inc. | 60,000 | 0.00 USD | deriv |
| 04 Dec 2020 | PURCHASE | Versartis, Inc. | 8,000 | 5.76 USD | |
| 22 Jan 2020 | GRANT_AWARD | Versartis, Inc. | 34,826 | 0.00 USD | deriv |
| 28 Feb 2019 | GRANT_AWARD | Versartis, Inc. | 38,000 | 0.00 USD | deriv |
| 12 Oct 2018 | GRANT_AWARD | Versartis, Inc. | 178,606 | — | |
| 12 Oct 2018 | GRANT_AWARD | Versartis, Inc. | 19,000 | — | deriv |
| 12 Oct 2018 | GRANT_AWARD | Versartis, Inc. | 38,001 | — | deriv |
| 12 Oct 2018 | GRANT_AWARD | Versartis, Inc. | 19,380 | — | deriv |
| 12 Oct 2018 | GRANT_AWARD | Versartis, Inc. | 19,000 | — | deriv |